drugset
drugset / Trial / NCT00633074

Non-inferiority Study of GSK Biologicals' Influenza Vaccine GSK576389A Using Different Formulations

NCT00633074 ↗

Phase 2 Completed 720 enrolled GlaxoSmithKline
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study is to show the non-inferiority of different formulations of GlaxoSmithKline Biologicials' influenza vaccine.

Timeline

Start
2008-03-03
Primary completion
2008-04-11
Completion
2008-04-11

Drugs

EvaluationDrugModalityDoseRoute
Subject GSK576389A Vaccine — Intramuscular

Indications

influenza